Market Overview - The Legal Cannabis Market has grown from USD 33.52 billion in 2024 to USD 42.91 billion in 2025, with a projected value of USD 144.18 billion by 2030, reflecting a compound annual growth rate (CAGR) of 27.52% [2][11]. - The market evolution is driven by legislative changes, consumer behavior, and technological advancements [2]. Industry Dynamics - Legislative changes and increasing consumer acceptance have led to a diverse range of products, including extracts and edibles, while regulatory bodies are enhancing quality control measures [3]. - Vertical integration and partnerships are essential for achieving scale and distribution advantages, with advances in cultivation improving yields and consistency [4]. - Federal developments are fostering optimism regarding interstate commerce and harmonized licensing and taxation frameworks [5]. Investment Trends - There is a noticeable shift towards ancillary services and strategic mergers and acquisitions, which are reshaping competitive landscapes and refining value creation across the supply chain [6]. - Decision-makers are gaining strategic insights to identify opportunities amid evolving consumer preferences and technological advancements [6]. Tariff Impact - New tariff structures in 2025 have increased costs for cultivation and processing, leading to reassessments of manufacturing locations and supplier networks [8]. - Retailers are facing margin pressures due to increased duties on imported machinery and packaging components, often passing costs to consumers [9]. - Regional operators are diversifying sourcing strategies to mitigate future tariff effects, fostering collaborative partnerships to maintain resilience [9]. Key Report Attributes - The report spans 193 pages, covering the forecast period from 2025 to 2030, with an estimated market value of USD 42.91 billion in 2025 and a forecasted value of USD 144.18 billion by 2030 [11].

NORWOOD, Mass., July 01, 2025 (GLOBE NEWSWIRE) -- Following today’s announcement that Delaware will commence adult-use sales of cannabis, MariMed CEO Jon Levine released the following statement: “We are excited to participate in the expansion of Delaware’s cannabis program to include adult-use sales. Our Delaware business unit, First State Compassion (“FSC”), was the first licensed operator in the state 10 years ago, and since then we have proudly served the state’s medical cannabis patients. The investment ...

Company Overview - Innovative Industrial Properties (IIPR) is a NYSE-listed REIT providing real estate capital to the regulated cannabis industry, founded in 2016[10] - The company has a diversified portfolio of over $2.4 billion in cannabis real estate[19] - IIPR's portfolio includes 108 properties (103 operating) across 19 states, with 82 million rentable square feet[24] Financial Performance - The company's Q4 2023 annualized dividend was $728 per share[24] - IIPR's Q4 2023 total revenue was $792 million[24] - The company's debt to total gross assets is 12%[53] Market and Portfolio - The regulated cannabis sales are estimated to grow to $43 billion by 2027[10] - The company's portfolio is diversified across 19 states, with a focus on industrial properties (92% of annualized base rent)[31] - The top ten tenants represent approximately 76% of the company's annualized base rent[48]

Core Insights - LEEF Brands Inc. is expanding nationally by acquiring a Type 1 Cannabis Processor License in New York, marking a significant milestone for the company [2][4] - The New York cannabis market has seen rapid growth, projected to reach $1.5 billion in retail sales in 2025, presenting a substantial opportunity for LEEF to leverage its extraction capabilities [3] Company Developments - The acquisition of the Type 1 Cannabis Processor License allows LEEF to engage in extraction, blending, infusion, packaging, labeling, and branding of its products, positioning it as a multi-state operator [2][3] - LEEF plans to replicate its successful California operations in New York, tailored to meet the specific demands of the local market [3][4] Market Context - The New York cannabis retail market grew from $160 million in 2023 to $1 billion in 2024, indicating a strong upward trend [3] - Concentrates account for approximately 55% of cannabis products sold in New York, highlighting the potential for LEEF's extraction capabilities to support growth in the region [3] Industry Engagement - LEEF will participate in the Benzinga Cannabis Capital Conference in Chicago on June 9-10, 2025, to connect with investors and industry leaders [5][6] - The executive team aims to build partnerships and share the company's growth story at the conference [7]

Q1 2025 Revenue of $28.0 millionQ1 2025 Net loss of $2.0 millionQ1 2025 Adjusted EBITDA loss of $2.5 million All figures are reported in United States dollars ($) unless otherwise indicated LAS VEGAS, May 14, 2025 (GLOBE NEWSWIRE) -- Planet 13 Holdings Inc. (CSE: PLTH) (OTCQX: PLNH) (“Planet 13” or the “Company”), a leading vertically-integrated multi-state cannabis company, today announced its financial results for the three-month period ended March 31, 2025. Planet 13’s financial statements are prepared i ...

Core Insights - High Tide Inc. has opened a new Canna Cabana retail cannabis store in Cochrane, Alberta, increasing its total store count to 196 across Canada, with 85 located in Alberta [1][4] - The new store is strategically positioned to serve over 8,000 residents in an area with no current cannabis retail competition, enhancing High Tide's market presence [2][4] - The company is actively pursuing entry into the German medical cannabis market, aiming to become a major importer and distributor of Canadian medical cannabis products [3][5] Company Expansion - The new Cochrane store reflects High Tide's commitment to expanding in markets with strong long-term potential, aiming to become the preferred cannabis retailer for local residents [4] - High Tide's Cabana Club loyalty program is gaining traction, with ELITE signups accelerating, indicating strong brand loyalty and customer engagement [4] - The company has generated $1.7 billion in Canadian cannabis sales since 2018, which has attracted interest from potential partners in Germany [3][5] Market Opportunities - The German medical cannabis market is experiencing rapid growth, with imported dried flower volumes exceeding 70 tons in 2024, more than doubling from the previous year [5] - High Tide is exploring alternative acquisition targets after pausing the Purecan acquisition, aiming to leverage its Canadian sales success to establish a foothold in the German market [5] - The company is focused on delivering an unmatched retail experience and providing value to customers as it expands its operations [4]

Industry Overview - The cannabis industry is experiencing consistent declines in stock prices despite long-term growth potential [1][2] - Investor confidence is low due to political uncertainty, particularly with Donald Trump's administration [2][3] Company Highlights - **Tilray Brands, Inc.**: Engages in the research, cultivation, processing, and distribution of medical cannabis products across multiple regions including Canada, the U.S., and Europe [4] - Recently ranked 4th in the Brewers Association 2024 annual report for top craft brewing companies in the U.S., up from 5th place, indicating growth in the craft brewing sector [6] - **Cronos Group Inc.**: Operates in the cultivation, production, distribution, and marketing of cannabis products internationally [7] - Anna Shlimak has been appointed as Chief Financial Officer, marking a significant leadership change within the company [9][10] - **Aurora Cannabis Inc.**: Involved in the production, distribution, and sale of cannabis products globally [10][12] - Recently launched the first inhalable resin cartridges for patients in the UK, Canada, and Australia, addressing a need for convenient consumption options [13]